33
/fr/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2150408
176282
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtenir le Premium
Create a timeline
Public timelines
FAQ
About & FeedbackUn accordConfidentialitéFAQ
Support 24/7  
CabinetGet premium
Donate

23 févr. 2012 - Ado-Trastuzumab Emtansine (T-DM1) Approved

Description:

FDA approves Ado-Trastuzumab Emtansine (T-DM1) for the treatment of patients with metastatic HER2-positive breast cancer. HER2 makes up 20% of all cases for breast cancer.

Ajouté au bande de temps:

Cancer Timeline

ByGabriel Tackett
15 nov. 2018
0
0
354

Date:

23 févr. 2012
Maintenaint
~ Il y a 13 ans
About & FeedbackUn accordConfidentialitéFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL